Your browser doesn't support javascript.
loading
Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma).
Zinzani, P L; Derenzini, E; Pellegrini, C; Rigacci, L; Fabbri, A; Gandolfi, L; Argnani, L; Casadei, B; Pulsoni, A; Gobbi, M; Perotti, A; Zaccaria, A; Voso, M T; Cabras, M G; De Renzo, A.
Afiliação
  • Zinzani PL; Department of Hematology and Medical Oncology "L. and A. Seràgnoli," S. Orsola-Malpighi Hospital, University of Bologna, Bologna. Electronic address: pierluigi.zinzani@unibo.it.
  • Derenzini E; Department of Hematology and Medical Oncology "L. and A. Seràgnoli," S. Orsola-Malpighi Hospital, University of Bologna, Bologna.
  • Pellegrini C; Department of Hematology and Medical Oncology "L. and A. Seràgnoli," S. Orsola-Malpighi Hospital, University of Bologna, Bologna.
  • Rigacci L; Department of Hematology, Azienda Ospedaliero-Universitaria Careggi, Firenze.
  • Fabbri A; Department of Hematology, Azienda Ospedaliero-Universitaria Senese, Siena.
  • Gandolfi L; Department of Hematology and Medical Oncology "L. and A. Seràgnoli," S. Orsola-Malpighi Hospital, University of Bologna, Bologna.
  • Argnani L; Department of Hematology and Medical Oncology "L. and A. Seràgnoli," S. Orsola-Malpighi Hospital, University of Bologna, Bologna.
  • Casadei B; Department of Hematology and Medical Oncology "L. and A. Seràgnoli," S. Orsola-Malpighi Hospital, University of Bologna, Bologna.
  • Pulsoni A; Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome.
  • Gobbi M; Department of Hematology, Azienda Ospedaliero-Universitaria San Martino, Genova.
  • Perotti A; Department of Hematology, S. Eugenio Hospital University "Tor Vergata," Rome.
  • Zaccaria A; Department of Hematology, S. Maria delle Croci Hospital, Ravenna.
  • Voso MT; Department of Hematology, La Cattolica University, Rome.
  • Cabras MG; Division of Hematology, Cagliari Hospital, Cagliari.
  • De Renzo A; Department of Hematology, Federico II University, Naples, Italy.
Ann Oncol ; 23(3): 805-807, 2012 Mar.
Article em En | MEDLINE | ID: mdl-22287683
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Folicular / Radioimunoterapia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2012 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Folicular / Radioimunoterapia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2012 Tipo de documento: Article